USPTO serial 97185263
Serial No. 97185263
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, JENNIFER MCGARRY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 97185263?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cecilia R. Dickson
Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded computer software and computer hardware for health platforms for neurological disorders for providing digital biomarkers and mathematical modelling of symptoms and treatment optimization algorithms for medical and diagnostic use; Downloadable and recorded computer software for use in the treatment of Parkinson's disease, namely, for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Downloadable and recorded Software as a Medical Device (SaMD) for treating neurological diseases; Downloadable and recorded computer software for evaluation, monitoring and management of medical data; Downloadable and recorded computer software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Downloadable and recorded computer software using artificial intelligence software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Downloadable and recorded computer application software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Downloadable and recorded computer software platforms for tracking, monitoring and evaluating symptoms and treatment of neurological diseases; Downloadable and recorded computer software for use in database and data and file management; Downloadable and recorded computer software platforms for enabling the secure and efficient transfer of tests and data between patients and health care providers; Downloadable and recorded computer application software for patients with medical conditions and diseases to provide tools, data and content for offering patients a better chance to manage their treatment plan, medication and care | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, patient devices with sensors to monitor, control and react to physical and physiological activity, including movements, vibrations, heartbeat, temperature, stress, sleep and a person's general activity | ACTIVE | — |
| 038 | Providing access to the Internet; Telecommunication access services, namely, providing access to platforms and portals on the Internet in the field of neurological diseases; Telecommunication access services, namely, providing access to information on the Internet and other data networks in the field of neurological diseases; Telecommunication access services, namely, providing access to computer programs in data networks for use in the treatment of Parkinson's disease and other neurological diseases; Telecommunication access services, namely, providing access to content, websites and portals containing relevant tools, data and content for offering patients a better chance to manage their treatment plan, medication and care; Telecommunication access services, namely, providing access to computer programs and databases for exchange of information between users of a computer network online forum in the field of health and medicine; Telecommunication access services, namely, providing online forums for transferring of messages relating to health and medicine between computer users; Providing an on-line forum for transmission of messages among computer users concerning health and medicine; Advisory, information and consultancy services relating to telecommunications | ACTIVE | — |
| 042 | Computer program development, updating and maintenance of computer software and database systems in the health care sector; Platform as a service (PaaS) featuring computer software platforms for analyzing medical data, classification and quantification of symptoms, clinical decision support and treatment optimization algorithms in the field of neurological diseases; Software as a service (SaaS) featuring software for diagnosis, collecting and analyzing user-generated big data, symptom classification and quantification as well as treatment optimization in the field of neurological diseases; Providing online non-downloadable software in the field of medical diagnosis, remote monitoring and motion detection; Platform as a service (PaaS) featuring computer software platforms for the automated analysis and diagnostic reporting of medical images, illnesses and patient data; Providing temporary use of online non-downloadable software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of online non-downloadable software for database management in the field of treatment of Parkinson's disease and other neurological diseases; Development of computer software in the field of medical diagnosis, analysis and monitoring; Providing online non-downloadable artificial intelligence software for medical diagnosis, analysis and monitoring; Testing, authentication and quality control, namely, product quality testing services and computer software testing services; Providing temporary use of non-downloadable cloud-based software for providing digital biomarkers and mathematical modelling of symptoms and treatment optimization algorithms for medical and diagnostic use; Providing temporary use of non-downloadable cloud-based software for use in the treatment of Parkinson's disease, namely, for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of non-downloadable cloud-based Software as a Medical Device (SaMD) for treating neurological diseases; Providing temporary use of non-downloadable cloud-based software for evaluation, monitoring and management of medical data; Providing temporary use of non-downloadable cloud-based software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Providing temporary use of non-downloadable cloud-based artificial intelligence software for diagnosis, remote monitoring, motion detection and data analysis in the field of neurological disorders; Providing temporary use of non-downloadable cloud-based software for collecting and tracking data relating to activity, including movements, vibrations, heartbeat, temperature, stress, sleep, photos, motion pictures, and a person's general activity, and for electronic warnings and telephone warnings to patients and health care providers relating to physical and physiological activity; Providing temporary use of non-downloadable cloud-based software platforms for tracking, monitoring and evaluating symptoms and treatment of neurological diseases; Providing temporary use of non-downloadable cloud-based software for use in database and data and file management; Providing temporary use of non-downloadable cloud-based software platforms for enabling the secure and efficient transfer of tests and data between patients and health care providers; Providing temporary use of non-downloadable cloud-based application software for patients with medical conditions and diseases to provide tools, data and content for offering patients a better chance to manage their treatment plan, medication and care; Advice, information and consulting services relating to computer software | ACTIVE | — |
| 044 | Providing information relating to treatment of neurological diseases via the Internet | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Stardots AB
- Other trademarks owned by Stardots AB
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 17, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 16, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 15, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 5, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 5, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 26, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 26, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2025 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Feb 26, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 25, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 25, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 28, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 28, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 28, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 28, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 7, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 5, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 5, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 5, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 5, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 21, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 2, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 2, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 2, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 25, 2021 | NWAP | NEW APPLICATION ENTERED | — |